Long-Term Health-Related Quality Of Life In Patients Treated With Subcutaneous C1-Inhibitor Replacement Therapy For The Prevention Of Hereditary Angioedema Attacks: Findings From The Compact Open-Label Extension Study (Vol 16, 86, 2021)